Raphael Pharmaceutical (RAPH) Shares Outstanding (Diluted) (2021 - 2025)
Raphael Pharmaceutical (RAPH) Shares Outstanding (Diluted) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 833.33 Mn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 20.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.55 Mn |
| Sep 30, 2025 | 19.63 Mn |
| Jun 30, 2025 | 19.63 Mn |
| Mar 31, 2025 | 19.63 Mn |
| Dec 31, 2024 | 18.67 Mn |
| Sep 30, 2024 | 18.70 Mn |
| Jun 30, 2024 | 18.68 Mn |
| Mar 31, 2024 | 18.62 Mn |
| Dec 31, 2023 | 16.72 Mn |
| Sep 30, 2023 | 16.44 Mn |
| Jun 30, 2023 | 16.11 Mn |
| Mar 31, 2023 | 15.96 Mn |
| Dec 31, 2022 | 14.34 Mn |
| Sep 30, 2022 | 15.06 Mn |
| Jun 30, 2022 | 13.65 Mn |
| Mar 31, 2022 | 13.04 Mn |
| Dec 31, 2021 | 11.17 Mn |
| Sep 30, 2021 | 12.13 Mn |
| Jun 30, 2021 | 10.81 Mn |